IPIC Message Board - Msg: 2231226

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Dec 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: paul001 who wrote (705)	9/19/1997 3:28:00 PM
From: Todd D. Wiener	of 1359

Check out BTIM, a stock with a market cap of $140 million, imminent marketing approval, and projected EPS (FY ending 6/00) of $4.50, with $11 projected for the following year. The stock trades at $44, up $11 this week. I believe that investing in highly speculative biotechs (such as those without earnings or marketed products) should be done only in companies with phase III products which will hit the market in the next 2 years or so. In addition, since there are no current earnings, the stock should be undervalued relative to its projected earnings, like IPIC and BTIM. GILD has received a lot more attention, causing its stock to run up. IPIC's excellent potential hasn't changed; only the short term facts have changed (Redux), producing a good buying opportunity. If one is to invest in these stocks, I think looking for speculative value is the best bet for superior profits. The investing style is different for profitable biotechs, like BCHE & CNTO. Todd

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next